1. Home
  2. Shareholder and Investor Information
  3. Outline of Securities Matters

Shareholder and Investor Information

Outline of Securities Matters

Fiscal Year From January 1 to December 31
Ordinary General Meeting of Shareholders During the Month of March
Record Date
  • Record Date of the Ordinary General Meeting of Shareholders
  • December 31
  • Record Date of Year-end Dividends
  • December 31
The company may pay interim dividends as of the record date, which is June 30, of each year. The company may fix a record date whenever necessary upon giving prior public notice.
Transfer Agent and Registrar for Common Stock Sumitomo Mitsui Trust Bank, Limited
4-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, Japan
Contact Information for Above Sumitomo Mitsui Trust Bank, Limited
Stock Transfer Agency Department
8-4, Izumi 2-chome, Suginami-ku, Tokyo, Japan
Unit Share 100 shares
Securities Identification Code 4579
Stock Exchange Listings Japan : Tokyo Stock Exchange
Method of Public Notice

Public notices of the Company shall be reported electronically. However, if any events of accident or other unavoidable circumstances that prevent electronic reporting arise, public notices of the Company shall be inserted in the "Nihon Keizai Shimbun".

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Press Release
Research & Development
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Potassium-Competitive Acid Blocker
5-HT4 Partial Agonist
5-HT2B Antagonist
Motilin Receptor Agonist
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Outline of Securities Matters
IR Library
IR Calendar
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release